Our Office

Formal Lectures

Formal Lectures

Dr. Maddahi has delivered countless lectures on the subject of heart-related conditions and treatments over the last 35 years. His many lectures have assisted aspiring medical students to better understand their field, heralding in a new generation of medical professionals. He has constantly strived to innovate and resolve complex physical situations related to his area of expertise.

Choose a period of time:

  • 1999

    1. Myocardial Perfusion/Function SPECT Workshop: Interesting Unknowns — Challenging Cases from Daily Nuclear Cardiology Practice
      Clinical Nuclear Cardiology: Case Review with the Experts American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, CA; January 29, 1999
    2. The Role of PET in Nuclear Cardiology
      Clinical Nuclear Cardiology: Case Review with the Experts American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 31, 1999
    3. Cost Effectiveness of Nuclear Cardiology
      The 3rd Symposium of Nuclear Cardiology, Columbian Association of Nuclear Medicine, Bogota, Columbia; February 19, 1999
    4. Prognostic Implications of Myocardial Perfusion
      The 3rd Symposium of Nuclear Cardiology
      Columbian Association of Nuclear Medicine, Bogota, Columbia; February 19, 1999
    5. Non-Invasive Imaging Methods for Assessment of Myocardial Viability: Recovery of Function Vs. Survival
      The 3rd Symposium of Nuclear Cardiology, Columbian Association of Nuclear Medicine, Bogota, Columbia; February 19, 1999
    6. Role of Nuclear Cardiology Techniques in Evaluation of Acute Chest Pain
      The 3rd Symposium of Nuclear Cardiology, Columbian Association of Nuclear Medicine, Bogota, Columbia; February 19, 1999
    7. Cost Effectiveness of FDG Metabolic Imaging in Cardiology and Oncology
      The 20th High Country Nuclear Medicine Conference, Vail, Colorado; March 1, 1999
    8. State-of-the-Art Clinical Applications of Cardiovascular Nuclear Medicine: Diagnosis, Prognosis and Myocardial Viability
      The 13th Annual Daniel R. Biello Memorial Lecture, Mallinckrodt Institute of Radiology, Washington University Medical Center, St. Louis, Missouri; March 8, 1999
    9. Department of Radiology Grand Rounds: Role of PET in Oncology
      Mallinckrodt Institute of Radiology, Washington University Medical Center, St. Louis, Missouri; March 8, 1999
    10. State-of-the-Art Nuclear Cardiology
      Kaiser Permanente Annual Cardiology Update, Universal City, California; March 13, 1999
    11. The 4th International Conference of Nuclear Cardiology
      Athens, Greece; April 20, 1999
    12. Scintigraphic Approaches to Assessment of Myocardial Perfusion: Physiologic Principles
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts,
      Bethesda, MD; May 13, 1999
    13. Myocardial Perfusion SPECT
      Workshop: Image Display and Interpretation
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts, Bethesda, MD; May 13, 1999
    14. Combined Perfusion/Function Studies and Pharmacologic Stress
      Workshop: How to Recognize SPECT Artifacts
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts, Bethesda, MD; May 14, 1999
    15. Relative Roles of PET and SPECT in the Future of Nuclear Cardiology
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts, Bethesda, MD; May 15, 1999
    16. Future Directions in Noninvasive Cardiac Imaging
      Workshop: Interesting unknowns — challenging cases from daily nuclear cardiology practice.
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts, Bethesda, Maryland; May 15, 1999
    17. Cost Effectiveness of PET in Nuclear Oncology
      The 46th Annual Meeting of the Society of Nuclear Medicine, Los Angeles, California; June 6, 1999
    18. Cost Effective Prognostication in CAD Using SPECT and PET Imaging
      The 46th Annual Meeting of the Society of Nuclear Medicine, Los Angeles, California; June 9, 1999
    19. How to Identify Myocardial Viability — Read with the Experts
      The 46th Annual Meeting of the Society of Nuclear Medicine, Los Angeles, California; June 10, 1999
    20. Assessing Myocardial Viability in Patients with Heart Failure
      The 9th Puerto Rican Congress of Caridiology, San Juan, Puerto Rico; July 17, 1999
    21. The Role of Nuclear Cardiology in the Next Millennium
      The 9th Puerto Rican Congress of Caridiology, San Juan, Puerto Rico; July 18, 1999
    22. Nuclear Cardiology Clinical Case Review
      American Society of Nuclear Cardiology Southern California Working Group Harbor-UCLA Medical Center, Torrance, California; August 14, 1999
    23. Pharmacological Agents for Nuclear Medicine
      The Society of Nuclear Medicine Technologist Section Southern California Chapter, Las Vegas, Nevada; September 10, 1999
    24. EKG Preparation and Interpretation
      The Society of Nuclear Medicine Technologist Section Southern California Chapter, Las Vegas, Nevada; September 10, 1999
    25. State-of-the-Art Nuclear Cardiology Applications in Diagnosis, Prognosis and Viability
      Assessment in Coronary Artery Disease
      Harbor-UCLA Medical Center Cardiology Grand Rounds, Torrance, California; September 28, 1999
    26. Gated SPECT and quantitative defect sizing.
      Optimizing Cardiac Imaging and Interpretation: Current and Future Techniques
      Baltimore, MD; September 29, 1999
    27. Read with the Experts
      American Society of Nuclear Cardiology's 4th Tutorial in Nuclear Cardiology, Washington, DC; October 1, 1999
    28. FDG SPECT Imaging: If it Works, Do We Need PET?
      American Society of Nuclear Cardiology's 4th Tutorial in Nuclear Cardiology, Washington, DC; October 1, 1999
    29. PET in Oncology
      16th Congress of the Latin American Society of Biology and Nuclear Medicine (ALASBIMN),
      Buenos Aires, Argentina; October 25, 1999
    30. Cost-Effectiveness of SPECT/PET Multifunctional Systems
      16th Congress of the Latin American Society of Biology and Nuclear Medicine (ALASBIMN),
      Buenos Aires, Argentina; October 26, 1999
    31. What does the Physician Need to Know About Cost-Effectiveness in Nuclear Cardiology?
      16th Congress of the Latin American Society of Biology and Nuclear Medicine (ALASBIMN),
      Buenos Aires, Argentina; October 26, 1999
    32. Risk stratification in Chronic Cardiomyopathy
      16th Congress of the Latin American Society of Biology and Nuclear Medicine (ALASBIMN), Buenos Aires, Argentina; October 26, 1999
    33. PET and SPECT for Risk Stratification and Viability Assessment — Comparison to Other Non-Invasive Imaging Modalities
      Upper Midwest Working Group of the American Society of Nuclear Cardiology, St. Paul, Minnesota; November 4, 1999
    34. State of the Art Applications of Nuclear Cardiology: Prognosis and Cost Effectiveness
      Sypmposium on Nuclear Cardiology, Focus on Myocardial Perfusion Imaging, Jaipur, India; November 11, 1999
    35. Trends in Cardiovascular Nuclear Medicine: Next Millennium
      The 2nd Annual Conference of Nuclear Cariological Society of India, New Delhi, India; November 13, 1999
    36. Assessment of Myocardial Viability with PET and SPECT
      The 2nd Annual Conference of Nuclear Cariological Society of India, New Delhi, India; November 14, 1999
    37. Role of Nuclear Techniques in Evaluation of Patients Following Revascularization
      The 2nd Annual Conference of Nuclear Cariological Society of India, New Delhi, India; November 14, 1999
    38. Cost-Effectiveness of Nuclear Cardiology in Acute Ischemic Syndromes: Moderator
      Southern California Working Group, The American Society of Nuclear Cardiology, Los Angeles, California; December 7, 1999
    39. Role of Gated Myocardial Perfusion SPECT in Assessment of Patients with Acute Coronary Syndromes
      Harbor-UCLA Medical Center Cardiology Grand Rounds, Torrance, California; December 13, 1999
  • 1998

    1. Comparative Roles of Nuclear Cardiology & Echocardiography for the Assessment of Myocardial Viability & Diagnosis & Prognosis of Coronary Artery Disease
      The 50th Annual Midwinter Radiological Conference of the Los Angeles Radiological Society, Los Angeles, California; January 17, 1998
    2. Cost-Effectiveness of Nuclear Cardiology for the Diagnosis & Prognosis of Coronary Artery Disease
      The 50th Annual Midwinter Radiological Conference of the Los Angeles Radiological Society, Los Angeles, California; January 17, 1998
    3. Scintigraphic Approach to Assessment of Myocardial Perfusion and Viability: Physiologic Principles
      Clinical Nuclear Cardiology: Case Review with the Experts American College of Cardiology
      Extramural Program at Cedars-Sinai Medical Center
      Los Angeles, California; January 30, 1998
    4. Workshop IX: Interesting Unknowns, Challenging Cases from Day-In, DayOut Nuclear Cardiology
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 30, 1998
    5. Workshop II Image Display and Interpretation Clinical Nuclear Cardiology: Case Review with the Experts American College of
      Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 30, 1998
    6. Clinical Dilemma: Selecting the Optimal Imaging Approach in Risk Assessment in Acute Coronary Syndromes Beyond Diagnosis in Ischemic Heart Disease: Advances in Cost-Effective risk Prognostication and Treatment; II International Meeting on Cardiac Imaging, Cortina d'Ampezzo, Italy; February 19, 1998
    7. Meet the Experts Beyond Diagnosis in Ischemic Heart Disease: Advances in Cost-Effective Risk Prognostication and Treatment; II International Meeting on Cardiac Imaging, Cortina d'Ampezzo, Italy; February 20, 1998
    8. Clinical Dilemma: Selecting the Optimal Imaging Approach for Prognostication Beyond
      Diagnosis in Ischemic Heart Disease: Advances in Cost-effective risk Prognostication and Treatment
      The 2nd International Meeting on Cardiac Imaging, Cortina d'Ampezzo, Italy; February 20, 1998
    9. Assessment of Myocardial Viability: Clinical Implications
      Loma Linda 10th Annual Cardiology Symposium, Loma Linda, California; March 4, 1998
    10. 18 FDG Studies in Patients with Lung Cancer
      PET/SPECT Imaging in Oncology, Los Angeles, California March 26, 1998
    11. PET Studies with Dual Detector Coincidence Imaging
      PET/SPECT Imaging in Oncology, Los Angeles, California March 27, 1998
    12. The 47th Annual Scientific Sessions of the American College of Cardiology
      Atlanta, Georgia; March 29 — April 1, 1998
    13. Assessment of Myocardial Viability by PET and SPECT
      The 28th Jornada Paulista de Radiologia, Sao Paulo, Brazil, April 20, 1998
    14. Clinical Role of PET/FDG Imaging in Lung Cancer and Solitary Pulmonary Nodules
      The 28th Jornada Paulista de Radiologia, Sao Paulo, Brazil April 20, 1998
    15. Applications of PET/FDG Imaging in Neurology: Epilepsy, Dementia, and Brain Tumors
      The 28th Jornada Paulista de Radiologia, Sao Paulo, Brazil April 20, 1998
    16. Cost-Effectiveness of FDG Metabolic PET and Coincidence Imaging In Oncology
      The 28th Jornada Paulista de Radiologia, Sao Paulo, Brazil April 20, 1998
    17. State of the Art Nuclear Cardiology for the Diagnosis and Prognosis of Coronary Disease
      The 28th Jornada Paulista de Radiologia, Sao Paulo, Brazil April 20, 1998
    18. Impact of Nuclear Cardiology Procedures on Cost-Effective Management of Patients
      Department of Medicine Grand Rounds, Sepulveda VA Medical Service, Sepulveda, California; April 23, 1998
    19. State of the Art Nuclear Cardiology for the Assessment of Coronary Artery Disease and Myocardial Viability
      The Society of Nuclear Medicine Hawaii Chapter Annual Spring Conference, Manoa, Hawaii; May 2, 1998
    20. Cost-Effective Role of FDG/PET Imaging in Oncology
      The Society of Nuclear Medicine Hawaii Chapter Annual Spring Conference, Manoa, Hawaii; May 8, 1998
    21. Scintigraphic Approach to Assessment of Myocardial Perfusion & Viability: Physiologic Principles
      Recent Advances in Nuclear Cardiology Featuring Read with the Expert, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 8, 1998
    22. Workshop I: Systematic Approach to Image Interpretation Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts Heart House Learning Center, Bethesda Maryland; May 8, 1998
    23. Cost-Effective Decision Making in Management of Coronary Artery Disease
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts Heart House Learning Center, Bethesda Maryland; May 8, 1998
    24. Workshop VII: Interesting Unknowns- Challenging Cases from Day in and Day Out Nuclear Cardiology Practice
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts Heart House Learning Center American College of Cardiology, Bethesda, Maryland; May 8, 1998
    25. The Role of PET in Oncology Seattle, Washington; June 1, 1998
    26. Myocardial Viability — Read with the Experts: PET Imaging
      The Society of Nuclear Medicine 45th Annual Meeting, Toronto, Canada; June 8, 1998
    27. New Imaging Methods in Cardiac Perfusion, Function and Metabolism: Moderator
      The Society of Nuclear Medicine 45th Annual Meeting, Toronto, Canada; June 9, 1998
    28. What is the Cost-Effectiveness of Myocardial Perfusion Imaging?
      The Society of Nuclear Medicine 45th Annual Meeting, Toronto, Canada; June 10, 1998
    29. Cardiovascular Clinical: Metabolism/Neuroendocrine: Co-moderator
      The Society of Nuclear Medicine 45th Annual Meeting, Toronto, Canada; June 10, 1998
    30. Nuclear Cardiology: Which Questions can be Answered Now, and in the Near and Further Future
      1998 International Symposium on Cardiovascular Imaging, Leiden, Netherlands; June 24, 1998
    31. FDG Tumor Imaging
      Summer School for the Nuclear Medicine Profession, Society of Nuclear Medicine Technologist Section, Las Vegas, Nevada; August 8, 1998
    32. Nuclear Cardiology in the ER
      Summer School for the Nuclear Medicine Professional, Society of Nuclear Medicine Technologist Section, Las Vegas, Nevada; August 8, 1998
    33. Workshop: SPECT Perfusion and Quantitation
      The 3rd ASNC Tutorial in Nuclear Cardiology, New Orleans, Louisiana; September 11, 1998
    34. Nuclear Medicine Update 1998
      Saint Agnes Medical Center, Fresno, California; October 3, 1998
    35. Prognostic Importance of Nuclear Procedures in Patients with Coronary Disease and Heart Failure
      Third Annual Convention of the Society of Nuclear Medicine of Puerto Rico, San Juan, Puerto Rico; October 10, 1998
    36. PET Imaging
      Integris Baptist Medical Center, Oklahoma City, Oklahoma; October 12, 1998
    37. PET Scans in CAD Prediction
      American Heart Association Scientific Sessions, San Francisco, California; October 26, 1998
    38. The 71st Sessions of the American Heart Association
      Dallas, Texas; November 8-11, 1998
    39. PET Scans in the Assessment of Silent Ischemia: Role in Predicition
      International Congress: Cardiology for the Consultant 1998, Buenos Aires, Argentina; November 20, 1998
    40. Nuclear Cardiology at the End of the Century Predicition
      International Congress: Cardiology for the Consultant 1998, Buenos Aires, Argentina; November 21, 1998
    41. Nuclear Imaging in the Diagnosis of Atherosclerosis
      International Congress: Cardiology for the Consultant 1998, Buenos Aires, Argentina; November 22, 1998
    42. Nuclear Medicine and the New Technology: Are They Necessary and Sufficient?
      International Congress: Cardiology for the Consultant 1998, Buenos Aires, Argentina; November 23, 1998
    43. Cost-Benefit of Nuclear Cardiology Studies in an Institutional Environment
      The 3rd Iberoamerican Symposium of Nuclear Cardiology, Punta Del Este, Uruguay; December 7, 1998
    44. Coincidence Imaging and High-Energy Collimation: Metabolic SPECT
      The 3rd Iberoamerican Symposium of Nuclear Cardiology, Punta Del Este, Uruguay; December 7, 1998
    45. Perspectives of Nuclear Cardiology for the Next Decade: Radiopharmaceuticals, Instrumentation and Software
      The 3rd Iberoamerican Symposium of Nuclear Cardiology, Punta Del Este, Uruguay; December 8, 1998
    46. Strategies for Incremental Use of Nuclear Cardiology in Clinical Practice
      The 3rd Iberoamerican Symposium of Nuclear Cardiology, Punta Del Este, Uruguay; December 8, 1998
    47. Is There a Role for Nuclear Cardiology in Nonischemic Cardiomyopathy?
      The 3rd Iberoamerican Symposium of Nuclear Cardiology, Punta Del Este, Uruguay; December 8, 1998
    48. EBCT in Assessing Chronic Heart Disease Risk in Asymptomatic People
      The 6th International Conference on Non-Invasive Cardiology, Jerusalem, Israel; December 20, 1998
    49. Assessment of Myocardial Viability with PET and SPECT
      The 6th International Conference on Non-Invasive Cardiology, Jerusalem, Israel; December 20, 1998
    50. Cost-Efficiency Considerations of Cardiac SPECT
      The 6th International Conference on Non-Invasive Cardiology, Jerusalem, Israel; December 20, 1998
    51. Advances in Non-invasive Cardiology: Monitoring Risk Factor Modification
      The 6th International Conference on Non-Invasive Cardiology, Jerusalem, Israel; December 20, 1998
  • 1997

    1. Scintigraphic Approach to Assessment of Myocardial Perfusion and Viability: Physiologic Principles
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 24, 1997
    2. Image Display and Interpretation
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 24, 1997
    3. Workshop IX: Interesting Unknowns, Challenging Cases from Day-In, Day-Out Nuclear Cardiology
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 26, 1997
    4. Role of Positron Emission Tomography in Cardiology and Oncology
      St. Claire Medical Center Medical Grand Rounds, Pittsburgh, Pennsylvania; February 18, 1997
    5. Cost Effective Applications of PET in Cardiology and Oncology
      St. Claire Medical Center Medical Grand Rounds, Pittsburgh, Pennsylvania; February 18, 1997
    6. Cost Efficiency of FDG-PET in Cardiology and Oncology
      Frankfurt PET Symposium at Johann Wolfgang Goethe University, Frankfurt, Germany; March 1, 1997
    7. The Clinical Decision Matrix of Cost Effective Cardiovascular Care: Viability Detection
      Chronic Left Ventricular Ischemic Dysfunction: The Quest for Cost Effictive Care, Cortina d'Ampezzo, Italy; March 4, 1997
    8. PET: Any Value Beyond SPECT? (Minicourse on Nuclear Cardiology: Clinical Application and Impact)
      Amercian College of Cardiology 46th Annual Scientific Sessions, Anaheim, California; March 16, 1997
    9. Cost Effectiveness of PET in Oncology in a Managed Care Environment
      Seminar on the Clinical Benefits of PET in Oncology, Chicago, Illinois; March 19, 1997
    10. Nuclear Cardiology as the Gate Keeper: Management of Patients with Suspected CAD
      The 3rd International Conference of Nuclear Cardiology, Florence, Italy; April 7, 1997
    11. New Diagnostic Approaches for Myocardial Perfusion: Moderator
      The 3rd International Conference of Nuclear Cardiology, Florence, Italy; April 7, 1997
    12. Meet with the Experts: MRI Imaging
      The 3rd International Conference of Nuclear Cardiology, Florence, Italy; April 8, 1997
    13. Role of PET in Oncology: Is it Cost Effective?
      Regional Oncology Seminar, Bellflower, California; April 19, 1997
    14. Scintigraphic Approach to Assessment of Myocardial Perfusion & Viability:
      Physiologic Principles
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 8, 1997
    15. Workshop I: Systematic Approach to Image Interpretation
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review wtih Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 8, 1997
    16. Cost-effective Decision Making in Management of Coronary Artery Disease
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 9, 1997
    17. Workshop VII: Interesting Unknowns - Challenging Cases from Day-In and Day-Out Nuclear Cardiology Practice
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 9, 1997
    18. Workshop VIII: Interesting Unknowns - Challenging Cases from Day-In and Day-Out Nuclear Cardiology Practice
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 10, 1997
    19. Update on Nuclear Medicine, Cardiology, and PET Scan
      Medical Grand Rounds at St. Francis Medical Center, Lynwood, California; May 13, 1997
    20. Electron Beam CT for CAD Detection: Complement or Competition?
      The 44th Annual Scientific Sessions of the Society of Nuclear Medicine, San Antonio, Texas; June 1, 1997
    21. Oncological Applications of FDG Imaging: Will it Survive in the Managed Care Era?
      The 44th Annual Scientific Sessions of the Society of Nuclear Medicine, San Antonio, Texas; June 1, 1997
    22. Cost Effectiveness and Economics of FDG Imaging
      The 44th Annual Scientific Sessions of the Society of Nuclear Medicine, San Antonio, Texas; June 2, 1997
    23. Perfusion Quantitation; Moderator
      The 44th Annual Scientific Sessions of the Society of Nuclear Medicine, San Antonio, Texas; June 4, 1997
    24. Cost Effectiveness of Myocardial Perfusion Imaging
      The 44th Annual Scientific Sessions of the Society of Nuclear Medicine, San Antonio, Texas; June 5, 1997
    25. Myocardial Perfusion Imaging: State of the Art
      The 21st Century Strategies in Cardiology: The 40th Anniversary of Shaio Clinical Foundation, Bogota, Colombia; June 6, 1997
    26. Myocardial Viability: Nuclear Cardiology vs. Dobuatmine Echocardiography
      The 21st Century Strategies in Cardiology: The 40th Anniversary of Shaio Clinical Foundation, Bogota, Colombia; June 6, 1997
    27. Cost Effectiveness of Nuclear Cardiology for Detection and Prognosis of CAD
      West Los Angeles VA Medical Centrer Cardiology Core Curriculum, Los Angeles, California; June 11, 1997
    28. New Developments in Nuclear Cardiology
      Los Angeles, California; June 11, 1997
    29. Read with the Experts: Basic
      The American Society of Nuclear Cardiology's 2nd Annual Tutorial in Nuclear Cardiology, Boston, Massachusetts; September 13, 1997
    30. Read with the Experts: Advanced
      The American Society of Nuclear Cardiology's 2nd Annual Tutorial in Nuclear Cardiology, Boston, Massachusetts; September 13, 1997
    31. Clinical Applications of PET Imaging
      The American Society of Nuclear Cardiology's 2nd Annual Tutorial in Nuclear Cardiology, Boston, Massachusetts; September 14, 1997
    32. Comparative Roles of Nuclear Cardiology Techniques Vs. Echocardiography
      The 22nd Western Regional Meeting of The Society of Nuclear Medicine, Monterey, California; September 18, 1997
    33. Nuclear Cardiology: Current State of the Art and Future Directions—George V. Taplin Memorial Lecture
      The 22nd Western Regional Meeting of The Society of Nuclear Medicine, Monterey, California; September 19, 1997
    34. Cost Effective Use of Nuclear Medicine to Triage Patients with Coronary Artery Disease
      The Annual Nuclear Medicine Seminar of The Los Angeles Radiological Society, Pasadena, California; October 4, 1997
    35. Cost Effectiveness of Nuclear Cardiology for Diagnosis and Prognosis of Coronary Artery Disease
      The 24th Argentine Congress of Cardiology, Buenos Aires, Argentina; October 19, 1997
    36. Role of Nuclear Techniques in Assessing Myocardial Viability and Selecting Heart Failure Patients for Myocardial Revascularization
      The 24th Argentine Congress of Cardiology, Buenos Aires, Argentina; October 19, 1997
    37. Nuclear Cardiology Vs. Echocardiography
      The 24th Argentine Congress of Cardiology, Buenos Aires, Argentina; October 19, 1997
    38. Detection of Ischemic Myocardium: Role of Nuclear Techniques in Decision Making
      The 24th Argentine Congress of Cardiology, Buenos Aires, Argentina; October 20, 1997
    39. Controversy: Myocardial Viability Vs. Nuclear Cardiology
      The 24th Argentine Congress of Cardiology, Buenos Aires, Argentina; October 20, 1997
    40. Cost Effectiveness of Nuclear Cardiology for Diagnosis and Prognosis of Coronary Artery Disease
      The 24th Argentine Congress of Cardiology, Buenos Aires, Argentina; October 21, 1997
    41. Chronic Angina in Multiple Vessel Disease: Detection of Ischemic Myocardium and Functional Stratification
      The 24th Argentine Congress of Cardiology, Buenos Aires, Argentina; October 21, 1997
    42. Value of Combined Evaluation of Perfusion and Function
      The 15th Congress of the Latin American Societies of Biology and Nuclear Medicine, Lima, Peru; October 26, 1997
    43. Cost Effectiveness of Non-Invasive Studies
      The 15th Congress of the Latin American Societies of Biology and Nuclear Medicine, Lima, Peru; October 26, 1997
    44. Cost Effectiveness of Oncologic FDG Imaging
      The 15th Congress of the Latin American Societies of Biology and Nuclear Medicine Lima, Peru; October 27, 1997
    45. Risk Stratification and Prognosis of Patients with Suspected and Known CAD
      The 15th Congress of the Latin American Societies of Biology and Nuclear Medicine, Lima, Peru; October 27, 1997
    46. New Developments in Assessing Cardiac Metabolism and Viability: Moderator
      New Frontiers in Cardiac Imaging
      The American Society of Nuclear Cardiology Symposium, the 70th Annual Scientific Sessions of the American Heart Association, Orlando, Florida; November 9, 1997
  • 1996

    1. Cost-effectiveness of PET vs. SPECT in evaluation of Coronary Artery Disease and Myocardial Viability
      The 48th Annual Midwinter Conference of the Los Angeles Radiological Society, Los Angeles, California; January 20, 1996
    2. Scintigraphic Approach to Assessment of Myocardial Perfusion and Viability: Physiologic Principles
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 26, 1996
    3. Workshop I: Principles of Image Interpretation
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 26, 1996
    4. Workshop IX: Interesting Unknowns, Challenging Cases from Day-In, Day-Out Nuclear Cardiology
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 28, 1996
    5. Cost Effectiveness of PET FDG Imaging in Clinical Oncology
      High Country Conference, Vail, Colorado; March 11, 1996
    6. Nuclear Cardiology; State of the Art and Future Directions
      Iranian Medical Society, Los Angeles, California; March 16, 1996
    7. Cost-Effective Selection of Patients for Coronary Angiography, Nuclear Cardiology and Managed Care: From Challenge to Opportunity
      The American Society on Nuclear Cardiology Symposium Preceding the American
      College of Cardiology Annual Scientific Sessions, Orlando, Florida; March 23, 1996
    8. Read with the Experts
      Great Lakes Nuclear Cardiology Symposium and Workshop, Chicago, Illinois; May 3, 1996
    9. Prognostication of Heart Failure Patients
      Great Lakes Nuclear Cardiology Symposium and Workshop, Chicago, Illinois; May 4, 1996
    10. Scintigraphic Approach to Assessment of Myocardial Perfusion & Viability:
      Physiologic Principles
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 9, 1996
    11. Workshop I: Systematic Approach to Image Interpretation
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 9, 1996
    12. Cost-Effective Decision Making in Management of Coronary Artery Disease
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 10, 1996
    13. Workshop VII: Interesting Unknowns - Challenging Cases from Day In and Day Out Nuclear Cardiology Practice
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 10, 1996
    14. Workshop VIII: Interesting Unknowns - Challenging Cases from Day In and Day Out Nuclear Cardiology Practice
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 11, 1996
    15. Molecular and Receptor Probes of Cardiolovascular Pathophysiology; Moderator
      Cardiovascular Council Categorical Course
      The 43rd Annual Meeting of The Society of Nuclear Medicine, Denver, Colorado; June 2, 1996
    16. Read With the Experts
      The 43rd Annual Meeting of The Society of Nuclear Medicine, Denver, Colorado; June 4, 1996
    17. Clinical Applications of PET in Cardiology and Oncology
      The 43rd Annual Meeting of The Society of Nuclear Medicine, Denver, Colorado; June 4, 1996
    18. The Cost Effectiveness of Viability Detection
      Matters of the Heart: Symposium on Nuclear Cardiology, the 43rd Annual Meeting of the Society of Nuclear Medicine, Denver, Colorado; June 5, 1996
    19. Cost Effectiveness of Noninvasive Algorithms for Diagnosis of Coronary Artery Disease
      The 3rd Invitational Nuclear Cardiology Workshop, Wintergreen, Virginia; July 14, 1996
    20. Evaluation of Myocardial Viability by Positron Emission Tomography
      Clinical Perspectives in Nuclear Cardiology, Mexican Society of Cardiology, Guadalajara, Mexico; August 30, 1996
    21. Role of Nuclear Techniques in Diagnosis of Myocardial Ischemia
      Clinical Perspectives in Nuclear Cardiology, Mexican Society of Cardiology, Guadalajara, Mexico; August 31, 1996
    22. Assessment of Prognosis in Patients with Coronary Artery Disease
      Clinical Perspectives in Nuclear Cardiology, Mexican Society of Cardiology, Guadalajara, Mexico; August 31, 1996
    23. Read with the Experts: Basic SPECT Orientation
      The 1st American Society of Nuclear Cardiology Tutorial in Nuclear Cardiology, Washington, DC; September 8, 1996
    24. Advanced Read with the Experts
      The 1st American Society of Nuclear Cardiology Tutorial in Nuclear Cardiology, Washington, DC; September 8, 1996
    25. Payment for Nuclear Cardiology: Diagnostic Related Codes
      The 1st American Society of Nuclear Cardiology Tutorial in Nuclear Cardiology, Washington, DC; September 9, 1996
    26. Evolving Role of Positron Emission Tomography in Oncology
      Rocky Mountain Nuclear Medicine Technologist Association Meeting, Presbyterian/ St. Lukes Medical Center, Denver, Colorado; October 5, 1996
    27. PET and SPECT in Cerebral Metabolism
      The 14th Colombian Congress of Internal Medicine, Bogota, Colombia; October 12, 1996
    28. Therapies with Radionuclides
      The 14th Colombian Congress of Internal Medicine, Bogota, Colombia; October 12, 1996
    29. Myocardial Viability: use of PET and SPECT
      The 14th Colombian Congress of Internal Medicine, Bogota, Colombia; October 12, 1996
    30. Plannary Session: Coronary Artery Disease Assessment
      The Second Iberoamerican Nuclear Cardiology Symposium, Pucon, Chile; October 14, 1996
    31. Which is the Best Protocol for Myocardial Perfusion Imaging?
      The Second Iberoamerican Nuclear Cardiology Symposium, Pucon, Chile; October 14, 1996
    32. Cost-Effective Ansaysis in Nuclear Cardiology
      The Second Iberoamerican Nuclear Cardiology Symposium, Pucon, Chile; October 14, 1996
    33. PET vs. SPECT for Myocardial Metabolism Evaluation
      The Second Iberoamerican Nuclear Cardiology Symposium, Pucon, Chile; October 15, 1996
    34. Role of Nuclear Cardiology in Detecting Coronary Artery Disease in Women and the Elderly
      The Second Iberoamerican Nuclear Cardiology Symposium, Pucon, Chile; October 16, 1996
    35. Pharmacologic Stress Testing as an Alternative to Exercise
      The Second Iberoamerican Nuclear Cardiology Symposium, Pucon, Chile; October 16, 1996
    36. Cost Effectiveness of Cardiac PET
      The 8th Annual International PET Conference, Orlando, Florida; October 25, 1996
    37. Workshop III B: Myocardial Perfusion with NH3
      The 8th Annual International PET Conference, Orlando, Florida; October 25, 1996
    38. Poster Highlights and Awards
      The 8th Annual International PET Conference, Orlando, Florida; October 26, 1996
    39. Nuclear Cardiology: Read with the Experts
      The 1st Canadian Nuclear Cardiology Society Meeting, Montreal, Canada; October 31, 1996
    40. Nuclear Screening and Pre-operative Viability Detection: The Clinical Decision Matrix of Cost Effective Cardio Vascular Care
      The American Society of Nuclear Cardiology Symposium Preceding the American Heart, Association Scientific Sessions, New Orleans, Louisiana; November 10, 1996
    41. Myocardial Viability and Prognosis; Moderator
      The 69th Scientific Sessions of the American Heart Association, New Orleans, Louisiana; November 11, 1996
    42. Myocardial Perfusion Imaging: Diagnostic and Prognostic Significance
      Minicourse on Cardiac Nuclear Medicine, the 82nd Scientific Assembly of the Radiological Society of North America, Chicago, Illinois; December 1, 1996
    43. Myocardial Perfusion Imaging Workshop
      Minicourse on Cardiac Nuclear Medicine, the 82nd Scientific Assembly of the Radiological Society of North America, Chicago, Illinois; December 2, 1996
  • 1995

    1. Scintigraphic Approach to Assessment of Myocardial Perfusion and Viability: Physiologic Principles
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 20, 1995
    2. Myocardial Perfusion Imaging: Panel Discussion
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 20, 1995
    3. Workshop II: Performance and Interpretation of Myocardial Perfusion Imaging-Planar and SPECT
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 20, 1995
    4. Workshop VIII: Clinician's Approach to Use of Nuclear Tests for Patient Management in Acute and Chronic CAD
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 22, 1995
    5. State of the Art Cardiac SPECT and PET Imaging for CAD and Myocardial Viability
      UCLA Department of Medicine Grand Rounds, Los Angeles, California; January 31, 1995
    6. Economics of Cardiac PET
      The 21st Annual Meeting of the American College of Nuclear Physicians, Cancun, Mexico; February 1, 1995
    7. Evaluation of Myocardial Viability
      Ignacio Chavez National Institute of Cardiology, Mexico City, Mexico; February 17, 1995
    8. Clinical Applications of Cardiac PET in Evaluation of Patients with Ischemic Cardiomyopathy
      Medical Society of Angeles Hospital, Mexico City, Mexico; February 17, 1995
    9. PET Imaging for Myocardial Viability Detection
      The Missouri Valley Nuclear Cardiology Working Group of the American Society of Nuclear Cardiology, St. Louis, Missouri; February 22, 1995
    10. Myocardial Viability
      University of California at Irvine, Cardiology Grand Rounds, Irvine, California; February 24, 1995
    11. Update on Myocardial Perfusion Imaging: What Agent and What Protocol?
      The 40th Annual Meeting - Society of Nuclear Medicine - Southwestern Chapter, San Antonio, Texas; March 3, 1995
    12. PET—From Basic Research to Today's Cost Effective Clinical Applications (Winfield Evans Memorial Lecture)
      The 40th Annual Meeting - Society of Nuclear Medicine - Southwestern Chapter, San Antonio, Texas; March 4, 1995
    13. Cardiac SPECT
      UCLA Radiology Board Review, Los Angeles, California; March 6, 1995
    14. Cost-Effective Decision Making for Diagnosis and Prognosis of CAD Myocardial Perfusion Imaging Compared to Other Modalities
      Nuclear Cardiology in the 90's: Harnessing Prognostic Power into Effective Clinical Decision Making, New Orleans, Louisiana; March 18, 1995
    15. Nuclear Cardiology: Read with the Experts
      American Society of Nuclear Cardiology Satellite Symposium, New Orleans, Louisiana; March 18, 1995
    16. Myocardial Perfusion (SPECT): Advantages and Indications Cardiac Imaging Technologies: Making Choices in the Context of Health Reform
      International Journal of Cardiac Imaging Satellite Symposium, New Orleans, Louisiana; March 18, 1995
    17. Cost-Effectiveness of Nuclear Cardiology Procedures in Management of Patients with Coronary Artery Disease New England Cardiology Working Group of the American Society of Nuclear Cardiology, Worcester, Massachusetts; April 10, 1995
    18. Update on the Role of Nuclear Cardiology in Diagnosis and Management of CAD
      Hartford Hospital Cardiology Grand Rounds, Hartford, Connecticut; April 11, 1995
    19. Read with the Experts
      The 2nd International Congress of Nuclear Cardiology, Cannes, France; April 23, 1995
    20. Cost-Effectiveness and Outcomes Analysis of Noninvasive Testing in Patients with CAD
      The 2nd International Congress of Nuclear Cardiology, Cannes, France; April 25, 1995
    21. What is the Current Clinical Utility of PET in Managing CAD?
      Cardiac PET in 1995: Clinical Reality or Academic Dream?
      The 2nd International Congress of Nuclear Cardiology, Cannes, France; April 25, 1995
    22. Scintigraphic Approach to Assessment of Myocardial Perfusion & Viability:
      Physiologic Principles
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 4, 1995
    23. Workshop I: Systematic Approach to Image Interpretation
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 4, 1995
    24. Cost-effective Decision Making in Management of Coronary Artery Disease
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 5, 1995
    25. Workshop VII: Interesting Unknowns - Challenging Cases from Day-In
      and Day-Out Nuclear Cardiology Practice
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 6, 1995
    26. How to Diagnose Ischemic Myocardium in 1995
      Nuclear Radiology Section Meeting, Los Angeles Radiologic Society, Los Angeles, California; May 11, 1995
    27. Myocardial Viability Assessment with PET Imaging
      Cardiovascular Nuclear Medicine-1995
      The 42nd Annual Meeting of the Society of Nuclear Medicine, Minneapolis, Minnesota; June 11, 1995
    28. Read with the Experts
      Advances in Radiotracers and Imaging of the Heart
      American Society of Nuclear Cardiology Satellite Symposium, the 42nd Annual Meeting of the Society of Nuclear Medicine, Minneapolis, Minnesota; June 14, 1995
    29. How can Nuclear Cardiology Procedures be more Cost-effective?
      American Society of Nuclear Cardiology Satellite Symposium, the 42nd Annual Meeting of the Society of Nuclear Medicine, Minneapolis, Minnesota; June 14, 1995
    30. Moderator: Myocardial Viability
      The 42nd Annual Meeting of the Society of Nuclear Medicine, Minneapolis, Minnesota; June 14, 1995
    31. Single Photon Imaging vs. Positron Emission Tomography
      The 42nd Annual Meeting of the Society of Nuclear Medicine, Minneapolis, Minnesota; June 15, 1995
    32. Cost-Effectiveness of PET in Cardiology and Oncology
      ADAC National Sales Meeting, Phoenix, Arizona; July 8, 1995
    33. PET for Detection of Coronary Artery Disease and Myocardial Viability
      The 20th Annual Meeting of the Society of Nuclear Medicine, Western Regional Chapter, Phoenix, Arizona; September 24, 1995
    34. Applications of Nuclear Cardiology in Acute Myocardial Infarction and Assessment of Reperfusion
      Symposium on Nuclear Cardiology, XXII Argentine Congress of Cardiology, Buenos Aires, Argentina; September 27, 1995
    35. Case Review and Panel Discussion
      Symposium on Nuclear Cardiology, XXII Argentine Congress of Cardiology, Buenos Aires, Argentina; September 27, 1995
    36. Usefulness of Nuclear Cardiology in Diagnosis and Prognosis of Coronary Artery Disease
      Symposium on Nuclear Cardiology, XXII Argentine Congress of Cardiology, Buenos Aires, Argentina; September 27, 1995
    37. Selection Criteria for Revascularization in Patients with Chronic CAD
      Symposium on Nuclear Cardiology, XXII Argentine Congress of Cardiology, Buenos Aires, Argentina; September 29, 1995
    38. Prognostic Stratification in Acute Myocardial Infarction
      Symposium on Nuclear Cardiology, XXII Argentine Congress of Cardiology, Buenos Aires, Argentina; September 29, 1995
    39. Prediction of Ventricular Function Recovery by Metabolic Imaging Using PET
      Symposium on Nuclear Cardiology, XXII Argentine Congress of Cardiology, Buenos Aires, Argentina; September 29, 1995
    40. Quantification of Myocardial Perfusion
      The 14th Congress of the Association of the Latin American Societies of Nuclear Medicine and Biology, Bahia, Brazil; October 11, 1995
    41. PET vs SPECT: Are the Sensitivities Getting Closer?
      The 14th Congress of the Association of the Latin American Societies of Nuclear Medicine and Biology, Bahia, Brazil; October 11, 1995
    42. Nuclear Cardiology: State of the Art
      The 14th Congress of the Association of the Latin American Societies of Nuclear Medicine and Biology, Bahia, Brazil; October 12, 1995
    43. Assessment of Myocardial Viability and Ischemia with PET: Comparison with SPECT
      and its Role in Patient Management
      Third Jerusalem Imaging Conference, Jerusalem, Israel; October 26, 1995
    44. Role of PET in Oncology: Is It Cost-Effective?
      Third Jerusalem Imaging Conference, Jerusalem, Israel; October 26, 1995
    45. How to Assess Myocardial Viability: Role of PET and SPECT
      The 68th Scientific Sessions of the American Heart Association, Anaheim, California; November 13, 1995
    46. The Myocardial Perfusion Imaging: Diagnostic and Prognostic Significance
      The 81st Scientific Assembly and Annual Meeting of the Radiologic Society of North America, Chicago, Illinois; November 29, 1995
    47. Myocardial Perfusion Imaging Workshop
      The 81st Scientific Assembly and Annual Meeting of the Radiologic Society of North America,
      Chicago, Illinois; November 30, 1995
    48. Evolving Roles of PET and SPECT: Competitive or Complementary?
      The 5th International Conference on Non-Invasive Cardiology, Tel-Aviv, Israel; December 17, 1995
    49. Outcome Assessment and Management of Patients with LV dysfunction: Cost-effective Role of Nuclear Cardiology
      The 5th International Conference on Non-Invasive Cardiology, Tel-Aviv, Israel; December 19, 1995
    50. Noninvasive Viability Assessment: Future Directions for Research
      The 5th International Conference on Non-Invasive Cardiology, Tel-Aviv, Israel; December 19, 1995
  • 1994

    1. Myocardial Viability: Update on Clinical Concepts & Innovations in the Management of Cardiovascular Diseases: State-of-the-Art for the Mid-90's
      University of Southern California School of Medicine, Laguna Beach, California; January 1994
    2. Scintigraphic Approachto Assessment of Myocardial Perfusion and Viability: Physiologic Principles
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 21, 1994
    3. Myocardial Perfusion Imaging: Panel Discussion
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 21, 1994
    4. Workshop I: Performance and Interpretation of Myocardial Perfusion Imaging-Planar and SPECT
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 21, 1994
    5. Workshop VIII: Clinician's Approach to Use of Nuclear Tests for Patient Management in Acute and Chronic CAD
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 23, 1994
    6. Cost Effectiveness of PET in Cardiology, Neurology, and Oncology
      UCLA Department of Pathology Grand Rounds, Los Angeles, California; February 9, 1994
    7. Clinical Role of PET in Neurology
      Critical Care Neurosurgery Program, Newport Beach, California; February 12, 1994
    8. Clinical Applications of PET Imaging in Oncology, Cardiology, and Neurology
      St. Joseph Medical Center Medical Grand Rounds, Burbank, California; March 22, 1994
    9. Clinical Role of PET Imaging in Management of Cardiac Patients
      Sepulveda VA Medical Center, Sepulveda, California; March 25, 1994
    10. Cost-Effective Applications of PET in Oncology
      City of Hope Medical Grand Rounds, Duarte, California; March 29, 1994
    11. Assessment of Myocardial Viability by SPECT and PET
      University of Southern California Cardiology Grand Rounds, Los Angeles, California; April 5, 1994
    12. Clinical Applications of SPECT Myocardial Imaging
      1994 Benedict Cassen Memorial Symposium, Southern California Chapter of the Society of Nuclear Medicine, Temple, Arizona; April 16, 1994
    13. Overview on the Role of Nuclear Techniques for Detection of Coronary Artery Disease and Myocardial Viability
      American-Israeli Symposium on Advances in Preventive and Clinical Cardiology, Tel Aviv, Israel; April 26, 1994
    14. Technical Pointers for the Performance of PET Scans: What a Technologist Should Know Nuclear Cardiology for the Technologist
      Heart House Learning Center, American College of Cardiology
      Bethesday, Maryland; April 27, 1994
    15. Workshop IV: Example Integration of Nuclear Cardiology with the Rest of the Clinical Picture
      Nuclear Cardiology for the Technologist, Heart House Learning Center, American College of Cardiology, Bethesday, Maryland; April 27, 1994
    16. Scintigraphic Approach to Assessment of Myocardial Perfusion & Viability: Physiologic Principles
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 28, 1994
    17. Workshop I: Thallium-201 Imaging—Planar & SPECT
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 28, 1994
    18. Workshop VI: Clinical Applications of Myocardial Perfusion SPECT—Part I
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 29, 1994
    19. Workshop VII: Clinical Applications of Myocardial Perfusion SPECT -Part II
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 30, 1994
    20. Clinical Applications of Cardiac Positron Emission Tomography
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 30, 1994
    21. Workshop VIII: Case Review with the Experts
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with Experts, Heart House Learning Center; American College of Cardiology, Bethesda, Maryland; April 30, 1994
    22. Update on Applications of PET and Neurology, Oncology, and Cardiology
      Forum on Role of Diagnostic Techniques in Medicine, Santa Monica Hospital, Santa Monica, California; May 17, 1994
    23. Assessment of Myocardial Viability by PET
      Cardiovascular Nuclear Medicine: 1994, the 41st Annual Meeting of the Society of Nuclear Medicine, Orlando, Florida; June 4, 1994
    24. SPECT Myocardial Perfusion Imaging: Debate on Nuclear Cardiology and Correlative Imaging for Detection and Evaluation of Coronary Artery Disease
      The 41st Annual Meeting of the Society of Nuclear Medicine, Orlando, Florida; June 6, 1994
    25. Oncology through the Eye of PET
      The 41st Annual Meeting of the Society of Nuclear Medicine, Orlando, Florida; June 7, 1994
    26. The Future of Clinical PET
      The 2nd Nuclear Cardiology Retreat, American Society of Nuclear Cardiology, Wintergreen, Virginia; July 11, 1994
    27. New Nuclear Agents: Where are we Going?
      The 23rd Annual Santa Fe Cardiology Symposium, Albuquerque, New Mexico; August 5, 1994
    28. Thallium Scintigraphy for Identifying Viability and Predicting Outcomes in Patients with Coronary Heart Disease
      The 23rd Annual Santa Fe Cardiology Symposium, Albuquerque, New Mexico; August 5, 1994
    29. Mechanism and Pharmacologic Management of Cardiac Arrhythmias
      UCLA Department of Pharmacology Graduate Course, Los Angeles, California; August 31, 1994
    30. Pathophysiology and Pharmacologic Management of Hyperlipidemias
      UCLA Department of Pharmacology Graduate Course, Los Angeles, California; September 2, 1994
    31. New Developments in Myocardial Perfusion Agents and Protocols
      Olive View Medical Center Radiology Grand Rounds, Sylmar, California; September 13, 1994
    32. Cardiac PET: When Is It Needed?
      Olive View Medical Center Radiology Grand Rounds, Sylmar, California; September 16, 1994
    33. Cost-Effectiveness of PET in Cardiology, Neurology, and Oncology
      Vancouver Hospital and Health Science Center, Vancouver, British Columbia; September 29, 1994
    34. Nonfunctional but Viable (Hibernating Myocardium: Methods for Detection and Approach to Therapy
      The A. Affiliate,
      Los Angeles, California; October 1, 1994
    35. Assessment of Coronary Disease and Myocardial Viability: PET vs SPECT
      First Ibero-American Symposium on Nuclear Cardiology, Pucon, Chile; October 3, 1994
    36. Clinical Case Discussions
      First Ibero-American Symposium on Nuclear Cardiology, Pucon, Chile; October 3, 1994
    37. Critique of Scientific Posters and Panel Discussion
      First Ibero-American Symposium on Nuclear Cardiology, Pucon, Chile; October 4, 1994
    38. Radionuclide Assessment of Thrombolytic Therapy in Acute Myocardial Infarction
      First Ibero-American Symposium on Nuclear Cardiology, Pucon, Chile; October 4, 1994
    39. Role of Radionuclide Techniques in Evaluation of Myocardial Revascularization
      First Ibero-American Symposium on Nuclear Cardiology, Pucon, Chile; October 5, 1994
    40. Development of Diagnostic Algorithms with PET in Cardiovascular Disease
      The 6th Annual International PET Conference, Washington, DC; October 13, 1994
    41. Workshop on Clinical Cardiology: Perfusion and Viability
      The 6th Annual International PET Conference, Washington, DC; October 13, 1994
    42. Applications of Thallium-201, Tc-99m Sestamibi, and Teboroxime
      Contemporary Nuclear Cardiology: Entering the 21st Century, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; October 17, 1994
    43. Perfusion Imaging: Read with the Experts
      Contemporary Nuclear Cardiology: Entering the 21st Century, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; October 17, 1994
    44. Workshop on Qualitative and Quantitative SPECT
      Contemporary Nuclear Cardiology: Entering the 21st Century, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; October 17, 1994
    45. Workshop on Myocardial Perfusion Imaging Protocols
      Contemporary Nuclear Cardiology: Entering the 21st Century, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; October 17, 1994
    46. Evaluation of Coronary Artery Disease: Read With the Experts
      Contemporary Nuclear Cardiology: Entering the 21st Century, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; October 17, 1994
    47. Myocardial Perfusion Imaging: Tl-201 and Tc-99m Sestamibi
      The 19th Annual Nuclear Cardiology Symposium and Workshop, Milwaukee, Wisconsin; October 20, 1994
    48. Assessment of Myocardial Viability using PET
      The 19th Annual Nuclear Cardiology Symposium and Workshop, Milwaukee, Wisconsin; October 21, 1994
    49. State of the Art: Nuclear Medicine
      Cardiac MRI Symposium, San Diego, California; October 21, 1994
    50. Is Cardiac MRI Another PET?
      Cardiac MRI Symposium, San Diego, California; October 21, 1994
    51. Diagnostic Methods in Coronary Heart Disease
      The 25th Annual Symposium on Future Trends in Cardiovascular Medicine, Los Angeles, California; November 6, 1994
    52. Clinical Utility of PET in Assessment of Myocardial Viability
      The 67th Annual Scientific Sessions of the American Heart Association, Dallas, Texas; November 14, 1994
    53. Myocardial Perfusion Imaging: Diagnostic and Prognostic Significance
      The 80th Annual Meeting of the Radiological Society of North America, Chicago, Illinois; November 27, 1994
  • 1993

    1. Thallium-201 Myocardial Perfusion SPECT: Practical Considerations and Clinical Applications
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars Sinai Medical Center, Los Angeles, California; January 21, 1993
    2. Myocardial Perfusion Imaging: Panel Discussion
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars Sinai Medical Center, Los Angeles, California; January 21, 1993
    3. Case Review with the Experts: Thallium-201 Imaging—Planar and SPECT
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars Sinai Medical Center, Los Angeles, California; January 21, 1993
    4. Workshop: Applications of Myocardial Perfusion SPECT
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars Sinai Medical Center, Los Angeles, California; January 22, 1993
    5. Clinical Cardiac Positron Emission Tomography: Making the Transition from SPECT to PET
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars Sinai Medical Center, Los Angeles, California; January 23, 1993
    6. The Role of Monoclonal Antibodies in Nuclear Cardiology
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars Sinai Medical Center, Los Angeles, California; January 23, 1993
    7. Workshop: Case Review with the Experts
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars Sinai Medical Center, Los Angeles, California; January 23, 1993
    8. Clinical Value of Positron Emission Tomography
      Kaiser Permanente Cardiology Grand Rounds, Los Angeles, California; February 17, 1993
    9. Clinical Applications of Cardiac PET
      UCLA Post Graduate Course on Positron Emission Tomography, Dana Point, California; March 1, 1993
    10. When to Use PET for Detection of Coronary Artery Disease
      UCLA Post Graduate Course on Positron Emission Tomography, Dana Point, California; March 1, 1993
    11. Workshop III: Cardiovascular Clinic
      UCLA Post Graduate Course on Positron Emission Tomography, Dana Point, California; March 1, 1993
    12. Nuclear Cardiology: Present Clinical Utility and Future Direction
      Medical Grand Rounds, Milwaukee VA Medical Center, Milwaukee, Wisconsin; March 3, 1993
    13. Clinical Role of PET General Electric
      Milwaukee, Wisconsin; March 3, 1993
    14. Secrets of a Successful Clinical and PET Center Medical College of Wisconsin
      Milwaukee, Wisconsin; March 3, 1993
    15. Issues of Myocardial Viability: Position for PET Cardiac Imaging in Coronary Artery
      Disease: Clinical Implications for Diagnosis, Prognosis and Viability
      American College of Cardiology Satellite Symposium, Anaheim, California; March 13, 1993
    16. Clinical Role of Tl-201 Myocardial Perfusion SPECT
      Quantitative Thallium and Technetium Myocardial SPECT 1993
      Emory University School of Medicine, Atlanta, Georgia; March 16, 1993
    17. Pharmacologic Stress Testing and Monoclonal Antibody Imaging
      Quantitative Thallium and Technetium Myocardial SPECT 1993
      Emory University School of Medicine, Atlanta, Georgia; March 16, 1993
    18. Stress Echocardiography vs. Stress Myocardioal Perfusion Imaging
      Society of Nuclear Medicine, Southern California Chapter, San Diego, California; March 20, 1993
    19. Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts
      Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 22-24, 1993
    20. Arterial and Coronary Thrombus Imaging Using Radiolabeled Monoclonal Antibodies
      The First International Congress of Nuclear Cardiology, Cannes, France; April 28, 1993
    21. Assessment of Myocardial Perfusion: Thallium and Technetium Perfusion Imaging
      The First International Congress of Nuclear Cardiology, Cannes, France; April 27, 1993
    22. Vessel Imaging: Chairman and Panelist
      The First International Congress of Nuclear Cardiology, Cannes, France; April 28, 1993
    23. Clinical Applications of PET in Cardiology, Neurology, and Oncology
      Centre Antoine Lacassagne, Nice, France; April 28, 1993
    24. Myocardial Perfusion Imaging: Tc-99m/Pharmacologic Agents
      Society of Nuclear Medicine, Pittsburgh Chapter, the 37th Annual Scientific Meeting Champion, Pennsylvania; May 8, 1993
    25. Clinical PET
      Society of Nuclear Medicine, Pittsburgh Chapter, the 37th Annual Scientific Meeting, Champion, Pennsylvania; May 9, 1993
    26. The Value of Angiographic Collaterals to Occluded Coronary Arteries in Predicting Myocardial Viability in Patients with LV Dysfunction
      Second International Symposium on Heart Failure—Mechanisms and Management, Geneva, Switzerland; May 17, 1993
    27. PET Assessment of Myocardial Viability Predicts Survival and Post Revascularization Improvement of Heart Failure Symptoms in Patients with LV Dysfunction
      Second International Symposium on Heart Failure—Mechanisms and Management, Geneva, Switzerland; May 19, 1993
    28. Advances in Clinical Applications of Cardiac PET
      Non-Invasive Cardiology for Physicians and Allied Health Professionals
      University of Rochester Medical Center, Rochester, New York; May 28, 1993
    29. Correlative Imaging—Cardiac PET
      The 40th Annual Meeting of The Society of Nuclear Medicine, Toronto, Canada; June 9, 1993
    30. Role of SPECT & PET in Prognosis and Management of, Patients with Left Ventricular Dysfunction
      The 40th Annual Meeting of the Society of Nuclear Medicine, Toronto, Canada; June 9, 1993
    31. Oncology through the Eye of PET
      The 40th Annual Meeting of the Society of Nuclear Medicine, Toronto, Canada; June 10, 1993
    32. What Reinject/Redistribution Protocol to Use with Thallium-201
      The 40th Annual Meeting of the Society of Nuclear Medicine, Toronto, Canada; June 11, 1993
    33. Imaging with Thallium-201
      The 18th Annual Nuclear Cardiology Symposium and Workshop, Milwaukee, Wisconsin; October 7, 1993
    34. Workshop on Myocardial Perfusion Imaging
      The 18th Annual Nuclear Cardiology Symposium and Workshop, Milwaukee, Wisconsin; October 7, 1993
    35. Assessment of Myocardial Viability with PET
      The 18th Annual Nuclear Cardiology Symposium and Workshop, Milwaukee, Wisconsin; October 8, 1993
    36. Clinical Applications of PET Breast Tumors and Head and Neck Tumors
      Society of Nuclear Medicine, Southeastern Chapter, Clearwater Beach, Florida; October 9, 1993
    37. Is PET Cost-Effective?
      Society of Nuclear Medicine, Southeastern Chapter, Clearwater Beach, Florida; October 9, 1993
    38. Cardiac Prognostication With PET
      The 4th International Conference on Non-Invasive Cardiology, Limassol, Cyprus; October 12, 1993
    39. Diagnostic Accuracy of Thallium-201 SPECT
      Cardiac SPECT Symposium and Workshop, Nantucket Island, Massachusetts; October 14, 1993
    40. Clinical Applications of Myocardial Perfusion SPECT
      Cardiac SPECT Symposium and Workshop, Nantucket Island, Massachusetts; October 15, 1993
    41. Workshop 2: Tc-99 MIBI SPECT
      Cardiac SPECT Symposium and Workshop, Nantucket Island, Massachusetts; October 15, 1993
    42. Economic Benefits of PET
      The 5th Annual International PET Conference of Institute for Clinical PET, McLean, Virginia; October 28, 1993
    43. Developments and Trends in Clinical Cardiac PET
      The 5th Annual International PET Conference of Institute for Clinical PET, McLean, Virginia; October 28, 1993
    44. State-of-the-Art Noninvasive Evaluation of Coronary Artery Disease
      Nuclear Cardiology Symposium, Century City, California; November 17, 1993
    45. Myocardial Viability PET vs. SPECT
      The 10th Argentine Congress of Biology and Nuclear Medicine, Buenos Aires, Argentina; November 24, 1993
    46. Myocardial Perfusion Imaging with Tc-99m Agents Update
      The 10th Argentine Congress of Biology and Nuclear Medicine, Buenos Aires, Argentina; November 24, 1993
    47. Pharmacologic Stress for Nuclear Cardiac Imaging
      The 10th Argentine Congress of Biology and Nuclear Medicine, Buenos Aires, Argentina; November 24, 1993
    48. Panel Discussion: Nuclear Cardiology
      The 10th Argentine Congress of Biology and Nuclear Medicine, Buenos Aires, Argentina; November 24, 1993
    49. PET in Oncology
      The 10th Argentine Congress of Biology and Nuclear Medicine, Buenos Aires, Argentina; November 24, 1993
    50. Panel Discussion: The Role of Nuclear Medicine in Oncology and Cardiology
      10th Argentine Congress of Biology and Nuclear Medicine
      Buenos Aires, Argentina; November 24, 1993
  • 1992

    1. Advances in Cardiac Imaging
      Cardiology Ground Rounds, Holy Cross Medical Center, Los Angeles, California; January 7, 1992
    2. SPECT Tl-201 Myocardial Perfusion Imaging: Practical Considerations and Clinical Applications
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 23, 1992
    3. Myocardial Perfusion Imaging: Panel Discussion
      Clinical Nuclear Cardiology: Case Review with the Experts,American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 23, 1992
    4. Workshop: Tl-201 Imaging-PLANAR and SPECT
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 23, 1992
    5. Applications of Exercise Perfusion and Function Imaging
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 24, 1992
    6. Future Directions in Noninvasive Cardiac Imaging and Acute Ischemic Syndromes:
      Moderator
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 25, 1992
    7. Clinical Cardiac Positron Emission Tomography (PET) Imaging: Making the Transition from SPECT to PET
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 25, 1992
    8. Role of Monoclonal Antibodies in Nuclear Cardiology
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 25, 1992
    9. Workshop: Myocardial Viability, Resting Ischemia, and PET
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 25, 1992
    10. Impact of PET on Healthcare Cost
      UCLA Post Graduate Course on PET, Dana Point, California; January 27, 1992
    11. Increasing Patient Referrals
      Practical Considerations of Clinical PET, UCLA Post Graduate Course on PET, Dana Point, California; January 27, 1992
    12. Detection of Coronary Artery Disease by PET
      UCLA Post Graduate Course on PET, Dana Point, California; January 28, 1992
    13. PET and the Heart: Moderator
      UCLA Post Graduate Course on PET, Dana Point, California; January 28, 1992
    14. Oncology and PET: Moderator
      UCLA Post Graduate Course on PET, Dana Point, California; January 29, 1992
    15. PET in Assessment of Myocardial Viability and Detection of Coronary Disease
      Los Angeles Radiologic Society 44th Annual Midwinter Meeting, Los Angeles, California; February 1, 1992
    16. Application of PET in Oncology and Neurology
      Los Angeles Radiologic Society 44th Annual Midwinter Meeting, Los Angeles, California; February 1, 1992
    17. PET Perfusion Imaging: Feasibility and Sensitivity
      Cardiovascular Imaging Symposium II, Clinical Applications of New Agents and Modalities, Lake Buena Vista, Florida; February 15, 1992
    18. Future Applications of PET
      Cardiovascular Imaging Symposium II, Clinical Applications of New Agents and Modalities, Lake Buena Vista, Florida; February 16, 1992
    19. Methods of Assessing Myocardial Viability: Panel Discussion
      Cardiovascular Imaging Symposium II, Clinical Applications of New Agents and Modalities, Lake Buena Vista, Florida; February 16, 1992
    20. Taking the Fear out of PET
      Nuclear Cardiology for the Technologist
      American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, CA; February 29, 1992
    21. Detection and Evaluation of Coronary Artery Disease: SPECT Tc-99m Labeled Agents, Pharmacologic Stress Testing
      American College of Nuclear Physicians Meeting, Coronado, California; March 5, 1992
    22. PET vs. SPECT for Assessment of Myocardial Perfusion and Viability
      American College of Nuclear Physicians Meeting, Coronado, California; March 5, 1992
    23. Clinical PET Experience at UCLA
      Los Angeles Radiologic Society, Los Angeles, California; March 5, 1992
    24. Antimyosin Image Interpretation
      International Symposium on Applications of Antimyosin Imaging in Clinical Cardiology,
      Frankfurt, West Germany; March 20, 1992
    25. Antimyosin Monoclonal Antibody Imaging Issues for the Community Hospital
      International Symposium on Applications of Antimyosin Imaging in Clinical Cardiology,
      Frankfurt, West Germany; March 20, 1992
    26. Impact of PET on Healthcare Cost
      Newport Diagnostic Center, Newport Beach, California; April 7, 1992
    27. PET/SPECT Cardiac Imaging
      SPECT/PET and Nuclear Cardiology Symposium, Southwestern Chapter of the Society of Nuclear Medicine Annual Meeting, San Antonio, Texas; April 9, 1992
    28. Workshop on the Applications of Tc-99m Sestamibi and Teboroxime
      SPECT/PET and Nuclear Cardiology Symposium
      Southwestern Chapter of the Society of Nuclear Medicine Annual Meeting, San Antonio, Texas; April 10, 1992
    29. Workshop on SPECT and Monoclonal Antibodies
      SPECT/PET and Nuclear Cardiology Symposium, Southwestern Chapter of the Society of Nuclear Medicine Annual Meeting, San Antonio, Texas; April 10, 1992
    30. Cardiovascular Nuclear Medicine: Past, Present, and Future: Ted Block Memorial Lecture
      Southwestern Chapter of the Society of Nuclear Medicine Annual Meeting, San Antonio, Texas; April 11, 1992
    31. Echocardiography or Nuclear Cardiology for the Noninvasive Diagnosis and Risk
      Stratification of Ischemic Heart Disease
      The 41st Annual Scientific Session of the American College of Cardiology, Dallas, Texas; April 12, 1992
    32. New Imaging Modalities: Fireside Panel
      The 41st Annual Scientific Session of the American College of Cardiology, Dallas, Texas; April 13, 1992
    33. Thallium Imaging-Viability and Prognosis: Moderator
      The 41st Annual Scientific Session of the American College of Cardiology, Dallas, Texas; April 13, 1992
    34. Clinical Application of PET for Detection of Coronary Artery Disease
      Newport Diagnostic Center, Newport Beach, California; April 29, 1992
    35. Taking the Fear Out of PET: A Technologist Guide to the Performance of Cardiac PET Imaging
      Nuclear Cardiology for the Technologist, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 20, 1992
    36. Thallium-201 Myocardial Perfusion Imaging: Practical Considerations and Clinical Applications
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 21, 1992
    37. SPECT Myocardial Perfusion: Panel Discussion
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 21, 1992
    38. Case Review with the Experts: SPECT Thallium-201 Imaging
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 21, 1992
    39. Workshop: Applications of Myocardial Perfusion SPECT
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 22, 1992
    40. Clinical Cardiac Positron Emission Tomography (PET) Imaging:
      Making the Transition from SPECT to PET
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 23, 1992
    41. Role of Monoclonal Antibody in Clinical Nuclear Cardiology
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 23, 1992
    42. Case Review with the Experts: Resting Ischemia, Myocardial Viability, PET, and Acute MI
      Recent Advances in Clinical Nuclear Cardiology Featuring Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; May 23, 1992
    43. Bayesian Analysis in the Interpretation of the Test Results
      Cardiovascular Nuclear Medicine 1992, the 39th Annual Meeting of the Society of Nuclear Medicine, Los Angeles, California; June 8, 1992
    44. Diagnosis of Coronary Artery Disease: Panel Discussion
      Cardiovascular Nuclear Medicine 1992, the 39th Annual Meeting of the Society of Nuclear Medicine, Los Angeles, California; June 8, 1992
    45. Advances in Tc-99m Teboroxime Myocardial Perfusion Imaging: Moderator
      The 39th Annual Meeting of the Society of Nuclear Medicine, Los Angeles, California; June 8, 1992
    46. Introduction to Myocardial Perfusion Imaging: Teboroxime vs Tl-201, Tc-99m sestamibi, and PET agents
      The 39th Annual Meeting of the Society of Nuclear Medicine, Los Angeles, California; June 8, 1992
    47. PET in the Diagnosis of Cardiovascular Disease
      Cardiovascular Nuclear Medicine 1992, the 39th Annual Meeting of the Society of Nuclear Medicine, Los Angeles, California; June 9, 1992
    48. Myocardial Imaging with Antimyosin Antibodies and MIBG: Moderator
      Cardiovascular Nuclear Medicine 1992, The 39th Annual Meeting of the Society of Nuclear Medicine, Los Angeles, California; June 11, 1992
    49. Clinical PET Sites: Review of Practical Experiences: Moderator
      The 39th Annual Meeting of the Society of Nuclear Medicine, Los Angeles, California; June 12, 1992
    50. The University Based Clinical PET Center at UCLA
      The 39th Annual Meeting of the Society of Nuclear Medicine, Los Angeles, California; June 12, 1992
    51. Great Debate of SPECT Vs. PET Imaging
      Florida Heart Institute Annual Symposium, Orlando, Florida; June 24, 1992
    52. Update on New Radionuclide Flow Agents
      Core Curriculum Lecture Series, Wadsworth V.A. Hospital, Los Angeles, CA; June 29, 1992
    53. What's New in SPECT?
      Society of Nuclear Medicine - Technologist Section, Mexican Baja, Mexico; August 1, 1992
    54. Making the Transition from SPECT to Clinical PET Imaging
      Society of Nuclear Medicine - Technologist Section, Mexican Baja, Mexico; August 2, 1992
    55. PET and SPECT Imaging
      New Modalities of Noninvasive Cardiac Testing, USC Fellows Symposium, Long Beach, CA; August 15, 1992
    56. Myocardial Perfusion Scintigraphy with Thallium-201 and Technetium 99m Sestamibi: Pros and Cons for Use of each Agent in Clinical Practice
      Symposium on Nuclear Cardiology and Echocardiography in Coronary Artery Disease,
      University of Chile, Santiago, Chile; August 21, 1992
    57. Pharmacologic Stress Testing: Critical Evaluation of Different Drugs and their
      Use in Conjunction with Nuclear Cardiology and Echocardiographic Techniques
      Symposium on Nuclear Cardiology and Echocardiography in Coronary Artery Disease,
      University of Chile, Santiago, Chile; August 21, 1992
    58. Use of Nuclear Cardiology Techniques in Risk Stratification in Coronary Artery Disease Symposium on Nuclear Cardiology and Echocardiography in Coronary Artery Disease, University of Chile, Santiago, Chile; August 21, 1992
    59. Myocardial Perfusion Imaging: Panel Discussion
      Symposium on Nuclear Cardiology and Echocardiography in Coronary Artery Disease,
      University of Chile, Santiago, Chile; August 21, 1992
    60. Applications of Nuclear Cardiology Techniques in Diagnosis of Complications and
      Risk Stratification in Acute Myocardial Infarction
      Symposium on Nuclear Cardiology and Echocardiography in Coronary Artery Disease,
      University of Chile, Santiago, Chile; August 22, 1992
    61. Assessment of Myocardial Viability Using Nuclear Cardiology Techniques:
      PET and SPECT
      Symposium on Nuclear Cardiology and Echocardiography in Coronary Artery Disease,
      University of Chile, Santiago, Chile; August 22, 1992
    62. Utility of Nuclear Cardiology Techniques in Evaluation of Cardiac Interventions: Reperfusion, Myocardial Revascularization, Evaluation of Short Term and Long Term Results
      Symposium on Nuclear Cardiology and Echocardiography in Coronary Artery Disease,
      University of Chile, Santiago, Chile; August 22, 1992
    63. Evaluation of Patients with Myocardial Infarction: Panel Discussion
      Symposium on Nuclear Cardiology and Echocardiography in Coronary Artery Disease, University of Chile, Santiago, Chile; August 22, 1992
    64. Detection of Coronary Artery Disease by PET
      The 60th Fall Symposium of the American Heart Association, Greater Los Angeles Affiliate,
      Los Angeles, CA; September 10, 1992
    65. Rational Selection of Patients With Severe Left Ventricular Dysfunction for Revascularization Using PET
      The Hospital of the Good Samaritan, Los Angeles, CA; September 21, 1992
    66. Myocardial Perfusion Imaging: Tl-201 vs Tc-99m Sestamibi / Teboroxime
      The 33rd Annual Meeting of the Southwestern Chapter of the Society of Nuclear Medicine
      Nashville, Tennessee; October 3, 1992
    67. Cardiac Imaging Concepts and Controversies
      The 33rd Annual Meeting of the Southwestern Chapter of the Society of Nuclear Medicine, Nashville, Tennessee; October 3, 1992
    68. Diagnostic Accuracy of Tl-201 SPECT
      Cardiac SPECT Symposium and Workshop, Nantucket Island, Massachusetts; October 9, 1992
    69. Workshop on Tl-201 Imaging
      Cardiac SPECT Symposium and Workshop, Nantucket Island, Massachusetts; October 9, 1992
    70. Clinical Applications of Tl-201 SPECT
      Cardiac SPECT Symposium and Workshop, Nantucket Island, Massachusetts; October 10, 1992
    71. Myocardial Perfusion Imaging With Tl-201
      The 17th Annual Nuclear Cardiology Symposium and Workshop, Milwaukee, Wisconsin; October 15, 1992
    72. Workshop on Myocardial Perfusion Imaging
      The 17th Annual Nuclear Cardiology Symposium and Workshop, Milwaukee, Wisconsin; October 15, 1992
    73. Applications of Antimyosin and Monoclonal Antibodies
      The 17th Annual Nuclear Cardiology Symposium and Workshop, Milwaukee, Wisconsin; October 16, 1992
    74. PET, SPECT, Planar: Detection of CAD-Which do we use and why PET in the Clinical Setting
      Dallas, Texas; October 24, 1992
    75. The Clinical Applications of PET in Cardiology
      The 17th Annual Western Regional Meeting of the Society of Nuclear Medicine, Phoenix, Arizona; October 25, 1992
    76. Clinical Applications of SPECT in Cardiology
      Interregional Training Course on Advanced SPECT With Emphasis in Brain and Heart Studies, International Atomic Energy Agency, Pisa, Italy; October 30, 1992
    77. Planar Versus SPECT Cardiac Studies: Indications and Limitations
      Interregional Training Course on Advanced SPECT With Emphasis in Brain and Heart
      Studies, International Atomic Energy Agency, Pisa, Italy; November 2, 1992
    78. Cardiac Imaging Workshop
      Cardiology Update Symposium, Institute for Medical Studies, Los Angeles, California; December 5, 1992
    79. Clinical Value of Positron Emission Tomography
      Newer Concepts in Cardiac Diagnostic and Therapeutics: 1992 and Beyond, Dana Point, California; December 12, 1992
    80. Diagnostic and Prognostic Applications of Exercise Myocardial Perfusion Imaging
      Sixth Annual Nuclear Cardiology Update: 1992, New York, New York; December 13, 1992
    81. New Developments in Nuclear Cardiology: SPECT, PET, Pharmacologic Stress, and Technetium Agents
      Sixth Annual Nuclear Cardiology Update: 1992, New York, New York; December 13, 1992
  • 1991

    1. Quantitative Planar and SPECT Thallium-201 Imaging: Practical Considerations and Clinical Applications.
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology extramural program at Cedars-Sinai Medical Center, Los Angeles, California; January 31, 1991
    2. Myocardial Perfusion imaging: Panel Discussion
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 31, 1991
    3. Case Review with the Experts: Thallium-201 Imaging; Planar and SPECT Clinical Nuclear
      Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 31, 1991
    4. Case Review with the Experts: Applications of Exercise Perfusion and Function Imaging Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology extramural program at Cedars-Sinai Medical Center, Los Angeles, California; February 1, 1991
    5. Moderator: Future Directions in Noninvasive Cardiac Imaging
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology extramural program at Cedars-Sinai Medical Center, Los Angeles, California; February 2, 1991
    6. The Role of Monoclonal Antibodies in Nuclear Cardiology
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology extramural program at Cedars-Sinai Medical Center, Los Angeles, California; February 2, 1991
    7. Case Review with the Experts: Acute Ischemic Syndromes
      Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; February 2, 1991
    8. Radionuclide Assessment of Myocardial Perfusion with Thallium, Technetium Labeled Agents and PET: State-of-the-Art and Future
      Mid Winter Meeting of the Los Angeles Radiological Society, Los Angeles, California; February 2, 1991
    9. Radionuclide Assessment of Myocardial Viability with Thallium, Technetium Labeled
      Agents and PET: State-of-the-Art and Future
      Mid Winter Meeting of the Los Angeles Radiological Society, Los Angeles, California; February 2, 1991
    10. PET, A Clinical Reality
      Advanced Biomedical Imaging Seminars, University of Southern California, Department of Radiology, Los Angeles, California; February 6, 1991
    11. Role of PET in Management of of Surgical Patients
      Department of Surgery Grand Round, UCLA, School of Medicine, Los Angeles, California; February 13, 1991
    12. Rubidium-82 Viability
      Squibb Diagnostics Speakers Update Meeting, Aventura, Florida; February 16, 1991
    13. Thallium-201 Planar Imaging: Technical Principles, Acquisitions and Processing Protocols, Quantitation, and Sources of Error
      Nuclear Cardiology for the Technologist, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; February 21, 1991
    14. PET and the Heart: Detection of Coronary Artery Disease
      UCLA Post Graduate Course on Positron Emission Tomography, Dana Point, California; February 26, 1991
    15. PET and Oncology: Detection and Monitoring of Primary and Secondary Tumors
      UCLA Post Graduate Course on Positron Emission Tomography, Dana Point, California; February 26, 1991
    16. PET Improves Health care Delivery at Lower Cost
      UCLA Post Graduate Course on Positron Emission Tomography, Dana Point, California; February 27, 1991
    17. UCLA Clinical PET Experience
      UCLA Post Graduate Course on Positron Emission Tomography, Dana Point, California; February 27, 1991
    18. Clinical PET Imaging
      Society of Nuclear Medicine: Technologist Section, Los Angeles, California; March 9, 1991
    19. The Role of Tc-99m sestamibi in clinical Practice
      Cardiac Imaging Workshop, San Francisco, California; March 13, 1991
    20. Advances in Cardiovascular Perfusion: SPECT
      The 2nd International Symposium on Computer Applications in Nuclear Medicine and Cardiac Magnetic Resonance Imaging, Rotterdam, The Netherlands; March 21, 1991
    21. Place for Hotspot Agents in Clinical Cardiology?
      The 1st Biennial Symposium of the European Working Group on Nuclear Cardiology,
      Rotterdan, The Netherlands; March 22, 1991
    22. Alternative Quantitative Approaches to Myocardial Perfusion Imaging
      Quantitative Thallium Myocardial Tomography: 1991, Emory University School of Medicine, Atlanta, Georgia; March 26, 1991
    23. Clinical Use of Antimyosin Antibodies
      Clinical Monoclonal Antibodies: Imaging and Therapy, the 36th Annual Meeting of the Southwestern Chapter of the Society of Nuclear Medicine, Oklahoma City, Oklahoma; April 4, 1991
    24. Thrombus Imaging by Monoclonal Antibodies
      Clinical Monoclonal Antibodies: Imaging and Therapy, the 36th Annual Meeting of the Southwestern Chapter of the Society of Nuclear Medicine, Oklahoma City, Oklahoma; April 4, 1991
    25. Clinical Case Conference on Monoclonal Antibody Applications
      Clinical Monoclonal Antibodies: Imaging and Therapy, the 36th Annual Meeting of the Southwestern Chapter of the Society of Nuclear Medicine, Oklahoma City, Oklahoma; April 5, 1991
    26. Application of Whole Body PET Imaging in Oncology
      The 36th Annual Meeting of the Southwestern Chapter of the Society of Nuclear Medicine, Oklahoma City, Oklahoma; April 5, 1991
    27. Quantitative Tomographic Thallium Imaging: Basic Principles, Techniques and Sources of Error
      Nuclear Cardiology for the Technologist, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 9, 1991
    28. Workshop: The Technologist Makes the Difference in SPECT Imaging Motion, Upward Creep, Bouncing Heart, Sources of False Positives and Negatives
      Nuclear Cardiology for the Technologist, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 9, 1991
    29. Quantitative Planar and SPECT Thallium-201 Imaging: Practical Considerations and Clinical Applications
      Clinical Nuclear Cardiology: Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 11, 1991
    30. Myocardial Perfusion Imaging: Panel Discussion
      Clinical Nuclear Cardiology: Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 11, 1991
    31. Case Review with the Experts: Thallium-201 imaging - Planar and SPECT
      Clinical Nuclear Cardiology: Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 11, 1991
    32. Applications: Post-MI, Post-CABG, Post-Cardiac catheterization and Prognosis
      Clinical Nuclear Cardiology: Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 12, 1991
    33. Cardiac Positron Emission Tomography (PET) Imaging - A Clinical Reality
      Clinical Nuclear Cardiology: Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 13, 1991
    34. The Role of Monoclonal Antibodies in Nuclear Cardiology Clinical Nuclear Cardiology:
      Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 13, 1991
    35. Recent Advances in Nuclear Cardiology: Technetium Labeled Agents and Pharmacologic Stress Testing
      Heart Lab, San Jose, California; April 17, 1991
    36. The Optimal Imaging Method in Coronary Disease Assessment: Panel Discussion
      The Non-Invasive Evaluation of Coronary Artery Disease: Its Importance for Diagnosis, Prognosis and Management, and Interaction with Invasive Methods UCSF Cardiology Update-Part II, San Francisco, California; May 4, 1991
    37. Tc-99m Isonitrile and the New Perfusion Imaging Agents - Comparison to Thallium-201 - Where Should we Apply Them?
      The Non-Invasive Evaluation of Coronary Artery Disease: Its Importance for Diagnosis,
      Prognosis and Management, and Interaction with Invasive Methods, UCSF Cardiology Update-Part II, San Francisco, California; May 4, 1991
    38. The Singular Advantages and Clinical Importance of PET Evaluation for Coronary Disease Evaluation
      The Non-Invasive Evaluation of Coronary Artery Disease: Its Importance for Diagnosis, Prognosis and Management, and Interaction with Invasive Methods, UCSF Cardiology Update-Part II, San Francisco, California; May 4, 1991
    39. The Current State and Future Development of PET Imaging-Does it Demonstrate Cost Effectiveness?: Panel Discussion
      The Non-Invasive Evaluation of Coronary Artery Disease: Its Importance for Diagnosis, Prognosis and Management, and Interaction with Invasive Methods, UCSF Cardiology Update-Part II, San Francisco, California; May 4, 1991
    40. Antimyosin Imaging for Diagnosis and Prognosis of Acute Ischemic Syndromes
      Application of Antimyosin Imaging in Clinical Cardiology, International Advisory Board Meeting, Wiesbaden, Germany; May 31, 1991
    41. PET Scanning
      Central California Heart Institute, Bakersfield Memorial Hospital Symposium, Bakersfield, California; June 8, 1991
    42. New Frontiers in Myocardial Perfusion Imaging: Moderator
      The Society of Nuclear Medicine, the 38th Annual Meeting, Cincinnati, Ohio; June 10, 1991
    43. A prospective on Myocardial Perfusion Imaging: Tl-201 Tc-99m Labeled Agents and the PET
      New Frontiers in Myocardial Perfusion Imaging
      The Society of Nuclear Medicine, the 38th Annual Meeting, Cincinnati, Ohio; June 10, 1991
    44. Myocardial Perfusion Imaging: New Methods: Moderator
      The Society of Nuclear Medicine, the 38th Annual Meeting, Cincinnati, Ohio; June 11, 1991
    45. Introduction to PET Scanning
      Current Status and the Clinical Applications of Positron Emission Tomography, John Muir Medical Center, Walnut Creek, California; June 22, 1991
    46. Tc-99m Sestamibi for Detection and Evaluation of Coronary Artery Disease
      International Nuclear Cardiology Workshop, Wintergreen, Virginia; July 16, 1991
    47. Thallium-201 Myocardial Perfusion Tomography: Physiologic and Technical
      Considerations and Quantitation
      Nuclear Cardiology Symposium, University of Chile, Santiago, Chile; August 1, 1991
    48. Clinical Usefulness of Myocardial Perfusion Imaging for Diagnosis and Prognosis of Coronary Artery Disease
      Nuclear Cardiology Symposium, University of Chile, Santiago, Chile; August 1, 1991
    49. Technetium-99m sestamibi and Technetium-99m teboroxime: Update 1991 Nuclear
      Cardiology Symposium, University of Chile, Santiago, Chile; August 1, 1991
    50. Pharmacologic Stress Resting with Dipyridamole and Adenosine: Practical Considerations
      Nuclear Cardiology Symposium, University of Chile, Santiago, Chile; August 1, 1991
    51. Myocardial Perfusion Imaging with SPECT Technique: Practical Considerations
      Nuclear Cardiology Symposium, University of Chile, Santiago, Chile; August 2, 1991
    52. Acute Myocardial Infarction: Prognosis and Risk Stratification
      Nuclear Cardiology Symposium, University of Chile, Santiago, Chile; August 2, 1991
    53. Role of Nuclear Cardiology in Assessment of Myocardial Viability
      Nuclear Cardiology Symposium, University of Chile, Santiago, Chile; August 2, 1991
    54. Positron Emission Tomography for Assessment of Myocardial Perfusion and Viability
      Nuclear Cardiology Symposium, University of Chile, Santiago, Chile; August 2, 1991
    55. Comparative Roles of Stress Echocardiography and Stress Myocardial Scintigraphy
      Nuclear Cardiology Symposium, University of Chile, Santiago, Chile; August 2, 1991
    56. SPECT vs. PET in Myocardial Perfusion Assessment
      Missouri Valley Chapter of the Society of Nuclear Medicine Annual Meeting, Columbia, Missouri; September 15, 1991
    57. Visual and Quantitative Analysis of Planar and SPECT Images
      Nuclear Cardiology - Advances in Interpretation and Practice, The Toronto Hospital, Toronto, Canada; September 27, 1991
    58. Generating the Optimal Report: Case demonstration
      Nuclear Cardiology - Advances in Interpretation and Practice, The Toronto Hospital, Toronto, Canada; September 27, 1991
    59. Myocardial Perfusion Imaging with Tl-201
      The 16th Annual Nuclear Cardiology Symposium and Workshop, Milwaukee, Wisconsin; October 9, 1991
    60. Cardiac Applications of PET
      The 16th Annual Nuclear Cardiology Symposium and Workshop, Milwaukee, Wisconsin; October 10, 1991
    61. Workshop on Tomogarphic Perfusion Imaging
      The 16th Annual Nuclear Cardiology Symposium and Workshop, Milwaukee, Wisconsin; October 10, 1991
    62. Cardiac Applications of Antimyosin and Other Monoclonal Antibodies
      The 16th Annual Nuclear Cardiology Symposium and Workshop, Milwaukee, Wisconsin; October 11, 1991
    63. The Utility of Nuclear Medicine Procedures for Diagnosis, Prognosis and Management of Patients with Coronary Artery Disease
      The 23rd Brazilian Congress of Radiology, Sao Paulo, Brazil; October 12, 1991
    64. Comparative Role of Imaging Techniques in Evaluation of Coronary Artery Disease:
      SPECT, PET, and MRI
      The 23rd Brazilian Congress of Radiology, Sao Paulo, Brazil; October 12, 1991
    65. New Developments in Myocardial Perfusion Imaging: Technetium Labeled Agents:
      The 23rd Brazilian Congress of Radiology, Sao Paulo, Brazil; October 13, 1991
    66. Role of Monoclonal Antibodies in Detection of Myocardial Necrosis and Thrombosis
      The 23rd Brazilian Congress of Radiology, Sao Paulo, Brazil; October 13, 1991
    67. Role of PET in Oncology
      The 23rd Brazilian Congress of Radiology, Sao Paulo, Brazil; October 14, 1991
    68. Role of PET in Evaluation of Patients with Neurological and Psychiatric Diseases
      The 23rd Brazilian Congress of Radiology, Sao Paulo, Brazil; October 14, 1991
    69. A Review of Cardiac Imaging: SPECT, PET, and MRI
      Cardiology Board Review, Los Angeles, California; October 26, 1991
    70. The Impact of PET Imaging in Medicine
      Medical Ground Rounds, Loma Linda University Medical Center, Loma Linda, California; October 30, 1991
    71. Oncologic Applications of PET
      Loma Linda University Medical Center, Loma Linda, California; October 30, 1991
    72. Recent Advances of PET Scanning in Cardiology
      Cardiology Ground Rounds, Loma Linda University Medical Center, Loma Linda, California; October 30, 1991
    73. SPECT Tl-201 Imaging
      Post Graduate Seminar on Myocardial Perfusion Imaging, the 64th Annual Scientific Meeting of the American Heart Association, Anaheim, California; November 10, 1991
    74. Clinical Applications of PET in Cardiology
      Good Samaritan Medical Center, Scottsdale, Arizona; November 8, 1991
    75. Clinical PET Center Experience at UCLA
      PET Advisory Board Meeting, Scottsdale, Arizona; November 9, 1991
  • 1990

    1. Quantitative Planar Thallium-201 Imaging: Technique and Practical Considerations Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 25, 1990
    2. Quantitative SPECT Thallium-201 Imaging: Technique and Practical Considerations Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 25, 1990
    3. Workshop on Planar Thallium-201 Imaging Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 25, 1990
    4. Workshop on SPECT Thallium-201 Imaging Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 25, 1990
    5. Myocardial Perfusion Imaging: Panel Discussion Clinical Nuclear Cardiology: Case Review with the Experts American College of Cardiology Extramural Program at Cedars-Sinai Medical Center Los Angeles, California; January 25, 1990
    6. Workshop on Patient Management Decisions American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 26, 1990
    7. Future Directions in Noninvasive Cardiac Imaging: Moderator Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 27, 1990
    8. Role of Monoclonal Antibodies in Nuclear Cardiology Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 27, 1990
    9. Workshop on Acute Ischemic Syndromes Clinical Nuclear Cardiology: Case Review with the Experts, American College of Cardiology Extramural Program at Cedars-Sinai Medical Center, Los Angeles, California; January 27, 1990
    10. Update on Clinical Applications of Myocardial Perfusion Imaging Heart Laboratory, San Jose, California; February 9, 1990
    11. Tc-99m Agents in Chronic Coronary Artery Disease: SPECT imaging Workshop on Tc-99m Myocardial Perfusion Imaging Agents and Their Relationship to Tl-201 Palm Beach, Florida; February 24, 1990
    12. Current Applications of Nuclear Techniques in Management of Cardiac Patients. Western New York Cardiovascular Society, Buffalo, New York; February 27, 1990
    13. Myocardial Imaging; Tc-99m Labeled Imaging Agents and Pharmacologic Stress Testing. The 3rd Annual Nuclear Medicine Symposium of Kaiser Permanante, Los Angeles, California; March 10, 1990
    14. Current Applications of Nuclear Techniques in Management of Patients with Cardiac Disease The 30th Annual E. Grey Dimond Cardiology for the Consultant, Scripps Clinic and Research Foundation, Rancho Santa Fe, California; April 2, 1990
    15. New Directions in Nuclear Cardiology: Technetium Labeled Agents for Myocardial Perfusion Imaging and Monoclonal Antibodies The 30th Annual E. Grey Dimond Cardiology for the Consultant, Scripps Clinic and Research Foundation, Rancho Santa Fe, California; April 2, 1990
    16. Quantitative Tomographic Thallium Imaging: Basic Principles, Techniques and Sources of Error Nuclear Cardiology for the Technologist, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 3, 1990
    17. Case Presentation: the Technologist Makes the Difference in SPECT imaging Nuclear Cardiology for the Technologist, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 3, 1990
    18. Quantitative Planar Thallium-201 Imaging: Technique and Practical Considerations Clinical Nuclear Cardiology: Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 4, 1990
    19. Quantitative SPECT Thallium-201 Imaging: Technique and Practical Considerations Clinical Nuclear Cardiology: Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 5, 1990
    20. Myocardial Perfusion Imaging: Panel Discussion Clinical Nuclear Cardiology: Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 5, 1990
    21. Workshop on planar Thallium-201 Imaging Clinical Nuclear Cardiology: Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 5, 1990
    22. Workshop on SPECT Thallium-201 Imaging Clinical Nuclear Cardiology: Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 5, 1990
    23. Workshop on Patient Management Decisions; POST- MI, CABG, PTCA, Cardiac Catheterization, and Prognosis Clinical Nuclear Cardiology: Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 6, 1990
    24. Workshop on Acute Ischemic Syndromes Clinical Nuclear Cardiology: Case Review with the Experts, Heart House Learning Center, American College of Cardiology, Bethesda, Maryland; April 7, 1990
    25. Assessing the Myocardium at Risk and its Viability. The 8th Annual Cardiology Seminar, Bellin Memorial Hospital/American Heart Association of Wisconsin, May 9, 1990
    26. Cardiology Moving into the 90's: Panel Discussion The 8th Annual Cardiology Seminar, Bellin Memorial Hospital/American Heart Association of Wisconsin, May 9, 1990
    27. How to Diagnose Ischemic Heart Disease in the 1990's: from Exercise Treadmill Testing to PET. Selected Topics in Preventive Cardiovascular Medicine, UCLA multicampus Division of Family Medicine, Santa Monica, CA; May 12, 1990
    28. What is the Significance of Transient Dilation of the Left Ventricle During Dipyridamole Thallium-201 Testing? European Association of Nuclear Medicine Congress, Amsterdam, The Netherlands; May 21, 1990
    29. Clinical Characteristics and Applications of Indium-111 Myoscint: Immunoscintigraphy in Clinical Medicine Satellite Symposium, European Association of Nuclear Medicine Congress, Amsterdam, The Netherlands; May 22, 1990
    30. Successful In-Vivo Visualization of Occlusive Arterial Thrombi by Tc-99m Labeled Monoclonal Antibody Against Activated Platelets European Association of Nuclear Medicine Congress, Amsterdam, The Netherlands; May 23, 1990
    31. The Utility of SPECT for Detection of Coronary Heart Disease The 37th Annual Meeting of Society of the Nuclear Medicine, Washington D.C.; June 18, 1990
    32. Applications of Antimyosin in the Management of Patients with Cardiac Disease: Imaging with Antibodies; Practical and Diagnostic Applications. The 37th Annual Meeting of Society of the Nuclear Medicine, Washington D.C.; June 18, 1990
    33. Myocardial Perfusion Imaging with the New Technetium Derivatives. Advances in Nuclear Cardiovascular Imaging The 37th Annual Meeting of Society of the Nuclear Medicine, Washington D.C.; June 18, 1990
    34. Detection of Coronary Thrombi by Tc-99m Radiolabeled Antifibrin Monoclonal Antibody The 37th Annual Meeting of Society of the Nuclear Medicine, Washington D.C.; June 19, 1990
    35. Rapid Imaging of Partially Occlusive Artrial Thrombus by Tc-99m Labeled Monoclonal Antibody Against Activated Platelets The 37th Annual Meeting of Society of the Nuclear Medicine, Washington D.C.; June 19, 1990
    36. Moderator: Cardiovascular Basic II: Myocardial Perfusion, Metabolism, and Methods. The 37th Annual Meeting of Society of the Nuclear Medicine, Washington D.C.; June 20, 1990
    37. Sources of Artifacts and Quality Assurance for Thallium-201 SPECT The 37th Annual Meeting of Society of the Nuclear Medicine, Washington D.C.; June 20, 1990
    38. Imaging Coronary Thrombi with Monoclonal Antibodies Scientific Conference on Experimental and Clinical Coronary Pathophysiology, American Heart Association, Durango, Colorado; Aug 10, 1990
    39. Clinical Characteristics and Applications of Indium-111 Myoscint in Patients with Ischemic Heart Disease Advances in Clinical Cardiology: Monoclonal Antibodies in Diagnosis and Therapy, the 12th Congress of the European Society of Cardiology, Stockholm, Sweden; September 18, 1990
    40. Tomographic Myocardial Imaging: General Principles The 15th Annual Nuclear Cardiology Symposium Workshop, Milwaukee, Wisconsin; October 11, 1990
    41. Workshop on Tomographic Perfusion Imaging. The 15th Annual Nuclear Cardiology Symposium Workshop, Milwaukee, Wisconsin; October 11, 1990
    42. Moderator: Myoscint Investigators Update Rancho Mirage, California; October 20, 1990
    43. Myoscint (Mifarmonab) Phase III Clinical Study Overview Myoscint Investigators Update, Rancho Mirage, California; October 20, 1990
    44. New Applications of Myoscint Myoscint Investigators Update, Rancho Mirage, California; October 20, 1990
    45. Multi Modality Imaging in Coronary Artery Disease; SPECT, PET, and MRI Valley Presbytarian Medical Center Medical Grand Rounds, Van Nuys, California; October 30, 1990
    46. Oncology and PET Symposium on The Role of Centralized PET Radiopharmacy in Clinical PET, Los Angeles, California; November 6, 1990
    47. Positron Emission Tomography: A Revolution in Medicine Rotary Club, Rancho Park Branch, Beverly Hilton Hotel, Los Angeles, California; November 7, 1990
    48. New Concepts in Prevention Diagnosis and Treatment of Coronary Artery Disease Persian Friends of the City of Hope, Santa Monica, California; November 8, 1990
    49. Identification of Viable Myocardium in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Thallium Scintigraphy The 63rd Scientific Session of the American Heart Association, Dallas, Texas; November 11, 1990
    50. Moderator: Nuclear Imaging: Jeopardized Myocardium and Prognosis The 63rd Scientific Session of the American Heart Association, Dallas, Texas; November 13, 1990
    51. Validation of Newly Developed Attenuation and Scatter Correction Methods for Quantitating Myocardial Perfusion by Tc-99m Sesta MIBI SPECT The 63rd Scientific Session of the American Heart Association, Dallas, Texas; November 14, 1990
    52. Noninvasive Imaging of Arterial Thrombi by Tc-99m Labeled Antiactivated Platelet Antibody The 63rd Scientific Session of the American Heart Association, Dallas, Texas; November 14, 1990
    53. Noninvasive Evaluation of Ischemic Cardiomyopathy The 27th Chilean Congress of Cardiology and Cardiovascular Surgery, Santiago, Chile; November 29, 1990
    54. Clinical Case Presentations in Cardiac Imaging The 27th Chilean Congress of Cardiology and Cardiovascular Surgery, Santiago, Chile; November 29, 1990
    55. Scintigraphic Evaluation of Myocardial Viability The 27th Chilean Congress of Cardiology and Cardiovascular Surgery, Santiago, Chile; November 30, 1990
    56. Sources of Artifacts and Quality Assurance with SPECT The 27th Chilean Congress of Cardiology and Cardiovascular Surgery, Santiago, Chile; November 30, 1990
    57. Comparative Clinical Value of SPECT and PET in Diagnosis of Coronary Artery Disease The 27th Chilean Congress of Cardiology and Cardiovascular Surgery, Santiago, Chile; December 1, 1990
    58. Application of Magnetic Resonance Imaging and Positron Emission Tomography in Cardiovascular Surgery The 27th Chilean Congress of Cardiology and Cardiovascular Surgery, Santiago, Chile; December 1, 1990
    59. Advances in Nuclear Cardiology: New Agents, Adenosine, and Monoclonal Antibodies The 27th Chilean Congress of Cardiology and Cardiovascular Surgery, Santiago, Chile; December 1, 1990
    60. Assessment of Myocardial Viability by Radionuclide Techniques PET vs SPECT The 3rd International Congress on Non-Invasive Cardiology, Tel-Aviv, Israel; December 17, 1990
    61. Moderator: Assessment of Myocardial Necrosis and Viability Following Ischemic Events The 3rd International Congress on Non-Invasive Cardiology, Tel-Aviv, Israel; December 18, 1990
    62. Detection and Evaluation of Valvular Regurgitation with NMR The 3rd International Congress on Non-Invasive Cardiology, Tel-Aviv, Israel; December 18, 1990
    63. Myocardial Perfusion Imaging with Radionuclide Techniques: PET vs Single Photon Imaging The 3rd International Congress on Non-Invasive Cardiology, Tel-Aviv, Israel; December 19, 1990
    64. PET for Assessment of Myocardial Viability: Future Prospects for Noninvasive Modalities in the Management of Patients with Heart Disease 3rd International Congress on Non-invasive cardiology Tel-Aviv, Israel; December 19, 1990

Call 310-824-4991 or Click Here to Schedule Your Cardiac Consultation.